References
- GreenRKodishSDiscussing a sensitive topic: nurse practitioners’ and physician assistants’ communication strategies in managing patients with erectile dysfunctionJ Am Acad Nurse Pract2009211269870519958421
- ShabsighRPerelmanMALaumannEOLockhartDCDrivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countriesBJU Int20049471055106515541128
- McKinlayJBThe worldwide prevalence and epidemiology of erectile dysfunctionInt J Impot Res200012Suppl 4S6S1111035380
- HatzichristouDGPescatoriESCurrent treatments and emerging therapeutic approaches in male erectile dysfunctionBJU Int2001Suppl 3111711578273
- DeanRCLueTFPhysiology of penile erection and pathophysiology of erectile dysfunctionUrol Clin North Am2005324379395v16291031
- LewisJHRosenRGoldsteinIErectile dysfunctionAm J Nurs2003103104857 quiz574814530708
- McCanceKLHuetherSEBrashersVLRoteNSPathophysiology: The Biologic Basis for Disease in Adults and Children6th edSt. LouisMosby2010
- Cranwell-BruceLADrugs for erectile dysfunctionMEDSURG Nursing2010193185191
- The United States Pharmacoepeial Convention<1151>Pharmaceutical dosage formsPharmacopeial Forum200935512711305
- European PharmacopeiaTabletsEd 42002Suppl 4(2)2435
- HiraniJJRathodDAVadaliaKROrally disintegrating tablets: a reviewTropic Journal of Pharmaceutical Research200982161172
- FuYYangSJeongSHKimuraSParkKOrally fast disintegrating tablets: developments, technologies, taste-masking and clinical studiesCrit Rev Ther Drug Carrier Syst200421643347615658933
- SperlingHDebruyneFBoermansABenekeMUlbrichEEwaldSThe POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunctionJ Sex Med201074 Pt 11497150720233275
- GittelmanMMcMahonCGRodriguez-RiveraJABenekeMUlbrichEEwaldSThe POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunctionInt J Clin Pract201064559460320456213
- DouglassMALinJCErectile dysfunction and premature ejaculation: underlying causes and available treatmentFormulary2010451727